Phosphoinositide 3′-kinase delta: turning off BCR signaling in Chronic Lymphocytic Leukemia

por Hoellenriegel, Julia, Burger, Jan A.
Publicado 2011

PI3K Signaling in Normal B Cells and Chronic Lymphocytic Leukemia (CLL)

por Okkenhaug, Klaus, Burger, Jan A.
Publicado 2015

Treatment algorithm for Japanese patients with chronic lymphocytic leukemia in the era of novel targeted therapies

por Kojima, Kensuke, Burger, Jan A.
Publicado 2020

Resistance Mutations to BTK Inhibitors Originate From the NF-κB but Not From the PI3K-RAS-MAPK Arm of the B Cell Receptor Signaling Pathway

por Smith, C. I. Edvard, Burger, Jan A.
Publicado 2021

Membranous nephropathy in chronic lymphocytic leukemia responsive to ibrutinib: A case report

por Turcotte, Anna-Eve, Glass, William F., Lin, Jamie S., Burger, Jan A.
Publicado 2023

Long-term control of refractory follicular lymphoma after treatment of secondary acute promyelocytic leukemia with arsenic trioxide (As(2)O(3)) and all-trans retinoic acid (ATRA)

por Jain, Preetesh, Konoplev, Sergej, Benjamini, Ohad, Romagura, Jorge, Burger, Jan A.
Publicado 2018

Regulation of Mcl-1 Expression in Context to Bone Marrow Stromal Microenvironment in Chronic Lymphocytic Leukemia()

por Balakrishnan, Kumudha, Burger, Jan A., Fu, Min, Doifode, Tejaswini, Wierda, William G., Gandhi, Varsha
Publicado 2014

Mesenchymal precursor cells in the blood of normal individuals

por Zvaifler, Nathan J, Marinova-Mutafchieva, Lilla, Adams, Gill, Edwards, Christopher J, Moss, Jill, Burger, Jan A, Maini, Ravinder N
Publicado 2000

Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia

por Fiorcari, Stefania, Maffei, Rossana, Audrito, Valentina, Martinelli, Silvia, Hacken, Elisa ten, Zucchini, Patrizia, Grisendi, Giulia, Potenza, Leonardo, Luppi, Mario, Burger, Jan A., Deaglio, Silvia, Marasca, Roberto
Publicado 2016

Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study

por Woyach, Jennifer A., Barr, Paul M., Kipps, Thomas J., Barrientos, Jacqueline C., Ahn, Inhye E., Ghia, Paolo, Girardi, Vincent, Hsu, Emily, Jermain, Mandy, Burger, Jan A.
Publicado 2023

Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukemia

por Zhang, Wan, Trachootham, Dunyaporn, Liu, Jinyun, Chen, Gang, Pelicano, Helene, Garcia-Prieto, Celia, Lu, Weiqin, Burger, Jan A, Croce, Carlo M, Plunkett, William, Keating, Michael J, Huang, Peng
Publicado 2012

The multi-kinase inhibitor TG02 induces apoptosis and blocks B-cell receptor signaling in chronic lymphocytic leukemia through dual mechanisms of action

por Chen, Rong, Tsai, Jennifer, Thompson, Philip A., Chen, Yuling, Xiong, Ping, Liu, Chaomei, Burrows, Francis, Sivina, Mariela, Burger, Jan A., Keating, Michael J., Wierda, William G., Plunkett, William
Publicado 2021

The BET Inhibitor GS-5829 Targets Chronic Lymphocytic Leukemia Cells and Their Supportive Microenvironment

por Kim, Ekaterina, ten Hacken, Elisa, Sivina, Mariela, Clarke, Astrid, Thompson, Philip A., Jain, Nitin, Ferrajoli, Alessandra, Estrov, Zeev, Keating, Michael J., Wierda, William G., Bhalla, Kapil N., Burger, Jan A.
Publicado 2019

A phase I-II trial of fludarabine, bendamustine and rituximab (FBR) in previously treated patients with CLL

por Jain, Nitin, Balakrishnan, Kumudha, Ferrajoli, Alessandra, O’Brien, Susan M., Burger, Jan A., Kadia, Tapan M., Cortes, Jorge E., Ayres, Mary L., Tambaro, Francesco Paolo, Keating, Michael J., Gandhi, Varsha, Wierda, William G.
Publicado 2016

Zanubrutinib for treatment‐naïve and relapsed/refractory chronic lymphocytic leukaemia: long‐term follow‐up of the phase I/II AU‐003 study

por Cull, Gavin, Burger, Jan A., Opat, Stephen, Gottlieb, David, Verner, Emma, Trotman, Judith, Marlton, Paula, Munoz, Javier, Johnston, Patrick, Simpson, David, Stern, Jennifer C., Prathikanti, Radha, Wu, Kenneth, Novotny, William, Huang, Jane, Tam, Constantine S.
Publicado 2021

Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells

por Rozovski, Uri, Calin, George A, Setoyama, Tetsuro, D’Abundo, Lucilla, Harris, David M, Li, Ping, Liu, Zhiming, Grgurevic, Srdana, Ferrajoli, Alessandra, Faderl, Stefan, Burger, Jan A, O’Brien, Susan, Wierda, William G, Keating, Michael J, Estrov, Zeev
Publicado 2013

The PI3-Kinase Delta Inhibitor Idelalisib (GS-1101) Targets Integrin-Mediated Adhesion of Chronic Lymphocytic Leukemia (CLL) Cell to Endothelial and Marrow Stromal Cells

por Fiorcari, Stefania, Brown, Wells S., McIntyre, Bradley W., Estrov, Zeev, Maffei, Rossana, O’Brien, Susan, Sivina, Mariela, Hoellenriegel, Julia, Wierda, William G., Keating, Michael J., Ding, Wei, Kay, Neil E., Lannutti, Brian J., Marasca, Roberto, Burger, Jan A.
Publicado 2013

Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts

por Malek, Alexandre E., Gutierrez, Cristina, Mulanovich, Victor E., Botdorf, Joshua, Chemaly, Roy F., Shah, Shivan, McCall, Brandi M., Melancon, Judd T., McConn, Kelly K., Borjan, Jovan, Raad, Issam I., Burger, Jan A., Garcia-Manero, Guillermo, Adachi, Javier A.
Publicado 2020

B cell receptor isotypes differentially associate with cell signaling, kinetics, and outcome in chronic lymphocytic leukemia

por Mazzarello, Andrea N., Gentner-Göbel, Eva, Dühren-von Minden, Marcus, Tarasenko, Tatyana N., Nicolò, Antonella, Ferrer, Gerardo, Vergani, Stefano, Liu, Yun, Bagnara, Davide, Rai, Kanti R., Burger, Jan A., McGuire, Peter J., Maity, Palash C., Jumaa, Hassan, Chiorazzi, Nicholas
Publicado 2022

Use of anticoagulants and antiplatelet in patients with chronic lymphocytic leukaemia treated with single‐agent ibrutinib

por Jones, Jeffrey A., Hillmen, Peter, Coutre, Steven, Tam, Constantine, Furman, Richard R., Barr, Paul M., Schuster, Stephen J., Kipps, Thomas J., Flinn, Ian W., Jaeger, Ulrich, Burger, Jan A., Cheng, Mei, Ninomoto, Joi, James, Danelle F., Byrd, John C., O'Brien, Susan M.
Publicado 2017